Novogene Co., Ltd. (688315.SS)
CNY 14.06
(0.21%)
CNY 14.06
(0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 214.87 Million CNY | 0.76% |
| 2022 | 212.45 Million CNY | -13.81% |
| 2021 | 246.49 Million CNY | 320.87% |
| 2020 | 58.56 Million CNY | -50.9% |
| 2019 | 119.27 Million CNY | 5.65% |
| 2018 | 112.89 Million CNY | 27.02% |
| 2017 | 88.88 Million CNY | 100.51% |
| 2016 | 44.32 Million CNY | 45.61% |
| 2015 | 30.44 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 21.78 Million CNY | -68.61% |
| 2024 Q2 | 50.5 Million CNY | 131.82% |
| 2024 Q3 | 63.85 Million CNY | 26.43% |
| 2023 Q2 | 61.22 Million CNY | 105.68% |
| 2023 Q3 | 53.67 Million CNY | -12.32% |
| 2023 Q4 | 69.4 Million CNY | 29.3% |
| 2023 Q1 | 29.76 Million CNY | -65.77% |
| 2023 FY | 214.07 Million CNY | 0.76% |
| 2022 Q1 | 22.25 Million CNY | -78.66% |
| 2022 Q4 | 86.96 Million CNY | 36.28% |
| 2022 Q3 | 63.81 Million CNY | 61.84% |
| 2022 Q2 | 39.42 Million CNY | 77.15% |
| 2022 FY | 212.45 Million CNY | -13.81% |
| 2021 Q3 | 53.42 Million CNY | 5.09% |
| 2021 FY | 246.49 Million CNY | 320.87% |
| 2021 Q4 | 104.31 Million CNY | 95.25% |
| 2021 Q2 | 50.83 Million CNY | 34.08% |
| 2021 Q1 | 37.91 Million CNY | -58.84% |
| 2020 Q3 | 21.89 Million CNY | 264.01% |
| 2020 Q2 | -13.34 Million CNY | 79.33% |
| 2020 FY | 58.56 Million CNY | -50.9% |
| 2020 Q1 | -64.59 Million CNY | -192.1% |
| 2020 Q4 | 92.11 Million CNY | 320.77% |
| 2019 Q4 | 70.13 Million CNY | 322.81% |
| 2019 Q3 | 16.58 Million CNY | -68.43% |
| 2019 Q2 | 52.54 Million CNY | 362.74% |
| 2019 FY | 119.27 Million CNY | 5.65% |
| 2019 Q1 | -20 Million CNY | -154.67% |
| 2018 Q1 | 12.75 Million CNY | 0.0% |
| 2018 Q4 | 36.58 Million CNY | 0.0% |
| 2018 FY | 112.89 Million CNY | 27.02% |
| 2018 Q3 | 36.58 Million CNY | 186.88% |
| 2018 Q2 | 12.75 Million CNY | 0.0% |
| 2017 FY | 88.88 Million CNY | 100.51% |
| 2016 FY | 44.32 Million CNY | 45.61% |
| 2015 FY | 30.44 Million CNY | 0.0% |